Israeli nuclear medicine developer UltraSPECT has received a U.S. patent, 7,026,623, for its "efficient single-photon emission imaging," according to the Haifa-based vendor.
According to the firm's patent, a shorter scanning time and clinically diagnostic images may be obtained by resolution recovery reconstruction methods such as its wide beam reconstruction (WBR) technology.
The company said it is developing the next generation of products based on the patent, with a goal of further reduction of scan time to less than three minutes.
By AuntMinnie.com staff writers
May 25, 2006
Related Reading
UltraSPECT brings Xpress.cardiac to Europe, January 18, 2006
UltraSPECT gets FDA nod, June 16, 2005
UltraSPECT gets CE mark, May 24, 2005
UltraSPECT builds client list, September 22, 2004
Copyright © 2006 AuntMinnie.com